This is the authors' abstract. We don't add key points for this paper.
Four patients who had received cadaveric renal allografts developed a profound and sustained leucopenia in association with a trimethoprim-sulphamethoxazole preparation. Ten other cadaveric renal allograft recipients received identical chemotherapy with no adverse effects. Statistical analysis showed that the association of leucopenia and trimethoprim-sulphamethoxazole therapy was dependent on the time after the transplantation procedure and was not related to the dosage of immunosuppressive chemotherapy or renal function.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hulme et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: